The population‐based prevalence of achondroplasia and thanatophoric dysplasia in selected regions of the US
- 12 August 2008
- journal article
- research article
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 146A (18), 2385-2389
- https://doi.org/10.1002/ajmg.a.32485
Abstract
There have been no large population‐based studies of the prevalence of achondroplasia and thanatophroic dysplasia in the United States. This study compared data from seven population‐based birth defects monitoring programs in the United States. We also present data on the association between older paternal age and these birth defects, which has been described in earlier studies. The prevalence of achondroplasia ranged from 0.36 to 0.60 per 10,000 livebirths (1/27,780–1/16,670 livebirths). The prevalence of thanatophoric dysplasia ranged from 0.21 to 0.30 per 10,000 livebirths (1/33,330–1/47,620 livebirths). In Texas, fathers that were 25–29, 30–34, 35–39, and ≥40 years of age had significantly increased rates of de novo achondroplasia among their offspring compared with younger fathers. The adjusted prevalence odds ratios were 2.8 (95% CI; 1.2, 6.7), 2.8 (95% CI; 1.0, 7.6), 4.9 (95% CI; 1.7, 14.3), and 5.0 (95% CI; 1.5, 16.1), respectively. Using the same age categories, the crude prevalence odds ratios for de novo cases of thanatophoric dysplasia in Texas were 5.8 (95% CI; 1.7, 9.8), 3.9 (95% CI; 1.1, 6.7), 6.1 (95% CI; 1.6, 10.6), and 10.2 (95% CI; 2.6, 17.8), respectively. These data suggest that thanatophoric dysplasia is one‐third to one‐half as frequent as achondroplasia. The differences in the prevalence of these conditions across monitoring programs were consistent with random fluctuation. Birth defects monitoring programs may be a good source of ascertainment for population‐based studies of achondroplasia and thanatophoric dysplasia, provided that diagnoses are confirmed by review of medical records.Keywords
This publication has 21 references indexed in Scilit:
- Frequency of Prenatal Diagnosis of Birth Defects in Houston, Galveston and the Lower Rio Grande Valley, Texas 1995Fetal Diagnosis and Therapy, 2000
- The Molecular and Genetic Basis of Fibroblast Growth Factor Receptor 3 Disorders: The Achondroplasia Family of Skeletal Dysplasias, Muenke Craniosynostosis, and Crouzon Syndrome with Acanthosis NigricansEndocrine Reviews, 2000
- Mutations in Fibroblast Growth-Factor Receptor 3 in Sporadic Cases of Achondroplasia Occur Exclusively on the Paternally Derived ChromosomeAmerican Journal of Human Genetics, 1998
- Epidemiology of osteochondrodysplasias: Changing trends due to advances in prenatal diagnosisAmerican Journal of Medical Genetics, 1996
- Monitoring Dominant Germ Cell Mutations Using Skeletal Dysplasias Registered in Malformation Registries: An International Feasibility StudyInternational Journal of Epidemiology, 1993
- Hungarian surveillance of germinal mutationsHuman Genetics, 1989
- Birth prevalence rates of skeletal dysplasiasClinical Genetics, 1989
- Congenital generalised bone dysplasias: a clinical, radiological, and epidemiological survey.Journal of Medical Genetics, 1989
- The birth prevalence rates for the skeletal dysplasias.Journal of Medical Genetics, 1986
- Achondroplasia and hypochondroplasia. Comments on frequency, mutation rate, and radiological features in skull and spine.Journal of Medical Genetics, 1979